B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
Also known as: B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06769 | Bendamustine | 1 | Active Not Recruiting | 1 |
| DB02379 | Beta-D-Glucose | 1 | Active Not Recruiting | 1 |
| DB02379 | Beta-D-Glucose | 1 | Suspended | 1 |
| DB14681 | Cortisone | 1 | Suspended | 1 |
| DB00531 | Cyclophosphamide | 1 | Active Not Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 | Suspended | 1 |
| DB00694 | Daunorubicin | 1 | Suspended | 1 |
| DB00997 | Doxorubicin | 1 | Suspended | 1 |
| DB00773 | Etoposide | 1 | Active Not Recruiting | 1 |
| DB00773 | Etoposide | 1 | Suspended | 1 |
| DB00099 | Filgrastim | 1 | Suspended | 1 |
| DB01073 | Fludarabine | 1 | Active Not Recruiting | 1 |
| DB09053 | Ibrutinib | 1 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB12240 | Polatuzumab vedotin | 1 | Suspended | 1 |
| DB00635 | Prednisone | 1 | Suspended | 1 |
| DB00073 | Rituximab | 1 | Suspended | 1 |